These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 914113)
1. [Effect of somatostatin in patients with high plasma growth hormone]. Pertzelan A; Doron M; Assa S; Keret R; Laron Z Harefuah; 1977 Aug; 93(3-4):74-6. PubMed ID: 914113 [No Abstract] [Full Text] [Related]
2. [Proceedings: Effect of somatostatine on plasma STH in acromegalic patients (author's transl)]. Milhaud G; Ribeiro F; Rivaille P Ann Endocrinol (Paris); 1974; 35(6):671-3. PubMed ID: 4463816 [No Abstract] [Full Text] [Related]
3. [Secretion of growth hormone and its anomalies]. Irie M; Tsushima T; Shizume K Saishin Igaku; 1968 May; 23(5):938-44. PubMed ID: 4883384 [No Abstract] [Full Text] [Related]
4. [Reserve capacity of hypophyseal trophic hormones in endocrine diseases. Reserve capacity of the growth hormone]. Laczi F; Julesz J; Szarvas G; Gáspár L; László F Orv Hetil; 1979 Jun; 120(24):1433-8. PubMed ID: 460862 [No Abstract] [Full Text] [Related]
5. The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. Laron Z; Pertzelan A; Doron M; Assa S; Keret R Horm Metab Res; 1977 Jul; 9(4):338-9. PubMed ID: 892700 [No Abstract] [Full Text] [Related]
6. Neural regulation of growth hormone secretion. Martin JB N Engl J Med; 1973 Jun; 288(26):1384-93. PubMed ID: 4575024 [No Abstract] [Full Text] [Related]
7. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
8. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. Laron Z; Pertzelan A; Karp M; Kowadlo-Silbergeld A; Daughaday WH J Clin Endocrinol Metab; 1971 Aug; 33(2):332-42. PubMed ID: 4935640 [No Abstract] [Full Text] [Related]
9. [Group discussion: on the 2d International Symposium on Growth Hormone]. Shizume K; Irie M; Matsuzaki S; Sawano S Horumon To Rinsho; 1971 Dec; 19(12):971-87. PubMed ID: 4400627 [No Abstract] [Full Text] [Related]
10. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
11. The suppression of blood growth hormone level by somatostatin infusion in patients with active acromegaly. Kwok CF; Ho LT Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):249-54. PubMed ID: 2907415 [No Abstract] [Full Text] [Related]
12. [Effects of somatostatin on the pituitary gland]. Kato Y; Chihara K; Abe H; Imura H Nihon Rinsho; 1976 Dec; 34(12):3484-90. PubMed ID: 1035289 [No Abstract] [Full Text] [Related]
13. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly. Kelijman M; Williams TC; Downs TR; Frohman LA J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro. Cap J; Marekova M; Cerman J; Malirova E; Suba P; Netuka D; Hana V; Marek J Gen Physiol Biophys; 2003 Jun; 22(2):201-12. PubMed ID: 14661732 [TBL] [Abstract][Full Text] [Related]
15. Human growth hormone secretion after exercise and oral glucose administration in patients with short stature. Okada Y; Hikata T; Ishitobi K; Wada M; Santo Y; Harada Y J Clin Endocrinol Metab; 1972 Jun; 34(6):1055-8. PubMed ID: 5020416 [No Abstract] [Full Text] [Related]
16. Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegaly. Oppizzi G; Botalla L; Verde G; Cozzi R; Liuzzi A; Chiodini PG J Clin Endocrinol Metab; 1980 Sep; 51(3):616-9. PubMed ID: 6106023 [TBL] [Abstract][Full Text] [Related]
17. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. Lamberts SW; Oosterom R; Neufeld M; del Pozo E J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119 [TBL] [Abstract][Full Text] [Related]
18. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [TBL] [Abstract][Full Text] [Related]
19. Interaction between somatostatin and TRH on growth hormone secretion in perifused human growth hormone tumor cells. Le Dafniet M; Garnier P; Brandi AM; Bression D; Scherrer H; Racadot J; Peillon F Horm Res; 1985; 21(4):235-9. PubMed ID: 2861154 [TBL] [Abstract][Full Text] [Related]
20. [On radio-immunologic determination of growth hormone in blood]. Melani F; Conrads R; Sorge F; Bartelt KM; Pfeiffer EF Verh Dtsch Ges Inn Med; 1965; 71():343-6. PubMed ID: 4291176 [No Abstract] [Full Text] [Related] [Next] [New Search]